Key result
Concomitant TEER and LAAO achieves 100% procedural success with no 90-day device thrombus.
Why the study?
Limited data exist evaluating the safety and feasibility of performing concomitant M-TEER and LAAO, procedures that share procedural requirements.
Does concomitant transcatheter edge-to-edge repair and left atrial appendage occlusion provide safe and feasible procedural and clinical outcomes in patients with mitral regurgitation and atrial fibrillation?
Observational (n=15)
No
Does concomitant transcatheter edge-to-edge repair and left atrial appendage occlusion provide safe and feasible procedural and clinical outcomes in patients with mitral regurgitation and atrial fibrillation?
Concomitant M-TEER and LAAO is technically feasible and safe, adding minimal procedural time while avoiding a second transseptal puncture and additional anesthesia.
Answers are grounded in this paper and cite their sources.
Concomitant M-TEER and LAAO appears feasible in select patients; hypothesis-generating and requires prospective trials before practice change.
Background/Objectives: Atrial fibrillation is a frequent comorbidity amongst patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER) for mitral regurgitation. Left atrial appendage occlusion (LAAO) can be performed to reduce the risk of stroke in patients with atrial fibrillation. Both procedures require large-bore venous access, transseptal puncture, and real-time imaging of the left atrium. However, limited data exist evaluating the safety and feasibility of concomitant M-TEER and LAAO. Methods: We performed a retrospective review of all concomitant M-TEER and LAAO procedures at our institution between May 2019 and September 2024 to evaluate the safety and feasibility of this approach. Results: Concomitant left atrial appendage occlusion was successful in all 15 patients, requiring an additional 15 min (IQR 11–29) of procedural time. No patients died or had a major vascular complication. Routine transesophageal echocardiography performed within 90 days showed no device related thrombus, and no significant peri-device leak in any patients. Conclusions: Concomitant M-TEER and LAAO are feasible but additional prospective studies or randomized trials are needed to evaluate the potential clinical benefit.
No takes yet. Share an insight, caveat, or question.
Prosperi-Porta et al. (2025) conducted an observational in Mitral regurgitation and atrial fibrillation (n=15). Concomitant Transcatheter Edge-to-Edge Repair and Left Atrial Appendage Occlusion was evaluated on Procedural success. Concomitant transcatheter edge-to-edge repair and left atrial appendage occlusion achieved 100% procedural success in 15 patients with no device-related thrombus or significant peri-device leak at 90 days.
Synapse has enriched 10 related papers. Consider them for comparative context: